Once for Life

Once for Life

Creating transformational gene therapies and peptide infusions that treat the most prevalent diseases to restore health and renew life.

Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive, one-time treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site


Latest News:  Sept. 22, 2016 | JCI Insight publishes preclinical results of urocortin 2 gene transfer in mouse models of insulin resistance

  Sept. 12, 2016 | Development-stage biotech Renova Therapeutics partners with NASDAQ Private Market

View All News
Subscribe to receive company press releases and announcements